Device Week, April 10, 2019 - Alcon Is Finally Free From Novartis; EOS Promotes 3D Ortho-Imaging

In this edition of Device Week, Catherine Longworth reports on eye-care giant Alcon's $28bn spin-off from Novartis. Marion Webb reviews her interview with executives from EOS imaging SA, a developer of imaging medical devices for orthopedics. Medtech Insight articles addressing topics discussed in this episode: All 'Bye' Itself: Alcon Spins Out From Novartis In $25Bn Stock Listing https://bit.ly/2G4qLhX Adios To Alcon In April As Novartis Confirms Spin-Off Date https://bit.ly/2Z1xbXA The Many Layers Of EOS Imaging – Surgical Planning, Low-Dose Imaging, 3D Services https://bit.ly/2Gf8lwd